Erytech Pharma SA operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Erytech Pharma SA with three other
pharmaceutical manufacturers in Europe:
sales of 5.84 million Euro [US$6.47 million]
of the United Kingdom
(£3.14 million [US$3.81 million]
of which 48%
was Consumer), and
based in Germany
(5.65 million Euro [US$6.26 million]
of which 100%
was Product sales).
During the year ended December of 2018, sales at
Erytech Pharma SA were 4.45 million Euro (US$4.92 million).
increase of 32.2%
versus 2017, when the company's sales were 3.36 million Euro.